Comparison of the three different cohorts demonstrated that no one in the COVID-19-naïve cohort was able to mount a strong IFN-γ response above 4x103 mIU/ml before their third vaccination, while after vaccination a low, but significant 18% of individuals reached such levels (Figure 5A). This evidence concerns the gene IFNG and COVID-19.